Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 1
1974 1
1975 1
1976 1
1980 1
1981 2
1982 2
1984 4
1986 3
1987 4
1988 5
1989 4
1990 2
1991 4
1992 3
1993 1
1995 2
1996 5
1997 3
1998 1
1999 7
2000 3
2001 4
2002 9
2003 5
2004 4
2005 11
2006 6
2007 3
2008 8
2009 6
2010 3
2011 1
2012 7
2013 7
2014 6
2015 5
2016 4
2017 6
2018 2
2019 3
2021 2
2022 3
2023 4
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
Wang SV, Pottegård A, Crown W, Arlett P, Ashcroft DM, Benchimol EI, Berger ML, Crane G, Goettsch W, Hua W, Kabadi S, Kern DM, Kurz X, Langan S, Nonaka T, Orsini L, Perez-Gutthann S, Pinheiro S, Pratt N, Schneeweiss S, Toussi M, Williams RJ. Wang SV, et al. Among authors: berger ml. Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):44-55. doi: 10.1002/pds.5507. Epub 2022 Oct 10. Pharmacoepidemiol Drug Saf. 2023. PMID: 36215113 Free PMC article.
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.
Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, Madigan D, Makady A, Schneeweiss S, Tarricone R, Wang SV, Watkins J, Daniel Mullins C. Berger ML, et al. Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1033-1039. doi: 10.1002/pds.4297. Pharmacoepidemiol Drug Saf. 2017. PMID: 28913966 Free PMC article.
Toward Facilitated Self-Service in Health Care.
Asch DA, Nicholson S, Berger ML. Asch DA, et al. Among authors: berger ml. N Engl J Med. 2019 May 16;380(20):1891-1893. doi: 10.1056/NEJMp1817104. N Engl J Med. 2019. PMID: 31091371 No abstract available.
Disturbed neurotransmitter homeostasis in ether lipid deficiency.
Dorninger F, König T, Scholze P, Berger ML, Zeitler G, Wiesinger C, Gundacker A, Pollak DD, Huck S, Just WW, Forss-Petter S, Pifl C, Berger J. Dorninger F, et al. Among authors: berger ml. Hum Mol Genet. 2019 Jun 15;28(12):2046-2061. doi: 10.1093/hmg/ddz040. Hum Mol Genet. 2019. PMID: 30759250 Free PMC article.
Cholinergic markers in ALS spinal cord.
Berger ML, Veitl M, Malessa S, Sluga E, Hornykiewicz O. Berger ML, et al. J Neurol Sci. 1992 Mar;108(1):114-7. doi: 10.1016/0022-510x(92)90196-r. J Neurol Sci. 1992. PMID: 1624947
162 results